Advanced search
Publication Cover
Cancer Investigation Volume 8, 1990 - Issue 5
Submit an article Journal homepage
23
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Chronic Calcium Antagonist Use in Carcinoma of the Lung and Colon: A Retrospective Cohort Observational Study

Leo R. Zacharski Norris Cotton Cancer Center Department of Medicine, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire; VA Medical Center White River Junction, Vermont, 05001
,
Thomas E. Moritz VA Cooperative Studies Program Coordinating Center VA Hospital Hines, Illinois, 60141
,
Clair M. Haakenson VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center VA Medical Center, Albuquerque, New Mexico, 87108
,
Joseph F. O'Donnell Norris Cotton Cancer Center Department of Medicine, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire
,
Harold S. Ballard Department of Medicine Columbia, University College of Physicians and Surgeons and the VA Medical Center, New York, New York, 10010
,
Gerhard J. Johnson Department of Medicine, University of Minnesota and the VA Medical Center, Minneapolis, Minnesota, 55417
,
Q. Scott Ringenberg Department of Medicine, University of Missouri Health Sciences Center and the VA Medical Center, Columbia, Missiouri, 65201
,
Richard L. Schilsky Department of Medicine, University of Missouri Health Sciences Center and the VA Medical Center, Columbia, Missiouri, 65201
,
Monica B. Spaulding Department of Medicine, State University of New York and the VA Medical Center, Buffalo, New York, 4215
,
Karl Tornyos Department of Medicine, Tulane University Medical School and the VA Medical Center, New Orleans, Louisiana, 70146
&
Charles C. Williams Department of Medicine, University of South Florida College of Medicine and the VA Medical Center, Tampa, Florida, 33612
 show all
Pages 451-458 | Published online: 11 Jun 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Didier Quilliot, Slimane Belbraouet, Xavier Pelletier, Jean-Louis Guéant, Jean Floquet & Gérard Debry. (1999) Influence of a High-Calcium Carbonate Diet on the Incidence of Experimental Colon Cancer in Rats. Nutrition and Cancer 34:2, pages 213-219.
Read now

Articles from other publishers (17)

Julia S. M. Zimmermann, Johannes Linxweiler, Julia C. Radosa, Maximilian Linxweiler & Richard Zimmermann. (2022) The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors. Frontiers in Physiology 13.
Crossref
Maximilian Linxweiler & Cornelia S. L. Müller. (2022) Rolle des SEC62 ‐Gens in der Dermatoonkologie – Relevanz für die Tumorzellbiologie, Prognoseeinschätzung und personalisierte Therapieplanung . JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:9, pages 1187-1200.
Crossref
Maximilian Linxweiler & Cornelia S. L. Müller. (2022) Role of the SEC62 gene in dermato‐oncology – impact on tumor cell biology, prognostication, and personalized therapy management . JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:9, pages 1187-1199.
Crossref
Sandrina Körner, Tillman Pick, Florian Bochen, Silke Wemmert, Christina Körbel, Michael D. Menger, Adolfo Cavalié, Jan-Philipp Kühn, Bernhard Schick & Maximilian Linxweiler. (2022) Antagonizing Sec62 function in intracellular Ca2+ homeostasis represents a novel therapeutic strategy for head and neck cancer. Frontiers in Physiology 13.
Crossref
Phyo T. Htoo, Til Stürmer, Michele Jonsson-Funk, Virginia Pate, Ross J. Simpson & Jennifer L. Lund. (2019) Renin–Angiotensin–Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries. Epidemiology 30:6, pages 867-875.
Crossref
Ferenc Zoltan Takacs, Julia Caroline Radosa, Maximilian Linxweiler, Mariz Kasoha, Rainer M. Bohle, Florian Bochen, Clara Unger, Erich-Franz Solomayer, Bernard Schick & Ingolf Juhasz-Böss. (2019) Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer. Archives of Gynecology and Obstetrics 299:5, pages 1405-1413.
Crossref
D. Cavalla. (2019) Using human experience to identify drug repurposing opportunities: theory and practice. British Journal of Clinical Pharmacology 85:4, pages 680-689.
Crossref
Maximilian Linxweiler, Bernhard Schick & Richard Zimmermann. (2017) Let’s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine. Signal Transduction and Targeted Therapy 2:1.
Crossref
D. Cavalla, E. Oerton & A. Bender. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 11 47 .
A. Pulkoski-Gross, J. Li, C. Zheng, Y. Li, N. Ouyang, B. Rigas, S. Zucker & J. Cao. (2014) Repurposing the Antipsychotic Trifluoperazine as an Antimetastasis Agent. Molecular Pharmacology 87:3, pages 501-512.
Crossref
George A. Makar, John H. Holmes & Yu-Xiao Yang. (2014) Angiotensin-Converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk. JNCI: Journal of the National Cancer Institute 106:2.
Crossref
Meric A. Altinoz, Ayhan Bilir, Rolando F. Del Maestro, Sevilcan Tuna, Emin Ozcan & Gunduz Gedikoglu. (2006) Noscapine and diltiazem augment taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro. Surgical Neurology 65:5, pages 478-484.
Crossref
Henrik T. S�rensen, J�rgen H. Olsen, Lene Mellemkj�r, Ane Marie Thulstrup, Flemming H. Steffensen, Joseph K. McLaughlin & John A. Baron. (2000) Cancer risk and mortality in users of calcium channel blockers. Cancer 89:1, pages 165-170.
Crossref
X. Wang. (1998) A chelate theory for the mechanism of action of aspirin-like drugs. Medical Hypotheses 50:3, pages 239-251.
Crossref
Murray Epstein. (1997) The Calcium Antagonist Controversy: The Emerging Importance of Drug Formulation as a Determinant of Risk. The American Journal of Cardiology 79:10, pages 9-19.
Crossref
Henry J Dargie. (1996) Calcium-channel blockers and the clinician. The Lancet 348:9026, pages 488-489.
Crossref
Willium J. M. Hrushesky. (1994) The department of veterans affairs' unique clinical cancer research effort. Cancer 74:S9, pages 2701-2709.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.